Drugs / Tetradecyl Sodium Sulphate
Tetradecyl Sodium Sulphate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01347294 | Aug 2011 → Nov 2023 | vascular malformation | Oslo University Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetradecyl Sodium Sulphate | “Compare the Effect of Bleomycin and Tetradecyl Sodium Sulphate in the Treatment of Venous Malformations” NCT01347294 ↗ |
| Known as | Fibrovein | “sodium tetradecyl sulfate (Fibrovein ™)” NCT01347294 ↗ |
| Known as | sodium tetradecyl sulfate | “sodium tetradecyl sulfate (Fibrovein ™)” NCT01347294 ↗ |